Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nephros Inc. (NEPH:NASDAQ), powered by AI.
Nephros Inc. is currently trading at $3.19. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nephros Inc. on Alpha Lenz.
View Nephros Inc.'s valuation metrics on Alpha Lenz.
“Nephros Inc.'s ROE is 12.7%. Explore profitability and growth together.”
Ask for details →Nephros Inc. is a company that specializes in the development and sale of filtration and ultrafiltration devices. Primarily focusing on providing high-quality, robust filtration solutions, Nephros serves medical institutions, commercial facilities, and the military sector. The company's product portfolio includes hemodiafilters and ultrafilters, which are integral in kidney dialysis and ensuring water is adequately purified for various healthcare and industrial applications. Nephros's technological advancements in filtration enhance safety and operational efficiency, impacting sectors like healthcare equipment manufacturing, water treatment, and hospitality services. By addressing the critical need for clean water and advanced dialysis treatments, Nephros plays a vital role in both enhancing public health standards and improving patient outcomes in medical settings.
“Nephros Inc.'s ROE is 12.7%. Explore profitability and growth together.”
Ask for details →Nephros Inc. (ticker: NEPH) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 31 employees.
The current price is $3.19 with a P/E ratio of -x and P/B of -x.
ROE is 12.71% and operating margin is 6.10%. Annual revenue is $19M.